H-1B sponsorship profile: KSQ Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, KSQ Therapeutics, Inc filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on KSQ Therapeutics, Inc’s H-1B petitions range from $107,361 at the low end to $276,056 at the high end, with a petition-weighted average of $148,693. That range reflects the mix of occupations the company sponsors, led by Scientist, Immunobiology (2 petitions at $120,000 avg), followed by Senior Scientist, Oncology Biology and Senior Director of Regulatory. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. KSQ Therapeutics, Inc is headquartered in Lexington, MA under NAICS code 54171, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where KSQ Therapeutics, Inc ranks. By H-1B petition volume, KSQ Therapeutics, Inc is #21,197 of 119,880 employers nationally and #921 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.